507 related articles for article (PubMed ID: 19798623)
41. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
Barrande G; Pittino-Lungo M; Coste J; Ponvert D; Bertagna X; Luton JP; Bertherat J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3779-85. PubMed ID: 11061538
[TBL] [Abstract][Full Text] [Related]
42. GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders.
Verrua E; Filopanti M; Ronchi CL; Olgiati L; Ferrante E; Giavoli C; Sala E; Mantovani G; Arosio M; Beck-Peccoz P; Lania AG; Spada A
J Clin Endocrinol Metab; 2011 Jan; 96(1):E83-8. PubMed ID: 20962023
[TBL] [Abstract][Full Text] [Related]
43. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
[TBL] [Abstract][Full Text] [Related]
44. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
45. Adequacy of current postglucose GH nadir limit (< 1 microg/l) to define long-lasting remission of acromegalic disease.
Ronchi CL; Arosio M; Rizzo E; Lania AG; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2007 Apr; 66(4):538-42. PubMed ID: 17371472
[TBL] [Abstract][Full Text] [Related]
46. Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.
Freda PU; Reyes CM; Nuruzzaman AT; Sundeen RE; Bruce JN
Pituitary; 2003; 6(4):175-80. PubMed ID: 15237928
[TBL] [Abstract][Full Text] [Related]
47. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
[TBL] [Abstract][Full Text] [Related]
48. Biochemical definitions of disease activity in acromegaly.
Conceição FL; Fisker S; Christiansen JS; Astrup J; Weeke J; Jørgensen JO
Growth Horm IGF Res; 2003; 13(2-3):98-103. PubMed ID: 12735931
[TBL] [Abstract][Full Text] [Related]
49. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
Arafat AM; Möhlig M; Weickert MO; Perschel FH; Purschwitz J; Spranger J; Strasburger CJ; Schöfl C; Pfeiffer AF
J Clin Endocrinol Metab; 2008 Apr; 93(4):1254-62. PubMed ID: 18171702
[TBL] [Abstract][Full Text] [Related]
50. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility.
Arafat AM; Müller L; Möhlig M; Mayr B; Kremenevskaya N; Pfeiffer AF; Buchfelder M; Schöfl C
Clin Endocrinol (Oxf); 2011 Nov; 75(5):685-91. PubMed ID: 21575028
[TBL] [Abstract][Full Text] [Related]
51. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
Puder JJ; Nilavar S; Post KD; Freda PU
J Clin Endocrinol Metab; 2005 Apr; 90(4):1972-8. PubMed ID: 15634715
[TBL] [Abstract][Full Text] [Related]
52. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
Brzana JA; Yedinak CG; Delashaw JB; Gultelkin HS; Cook D; Fleseriu M
Pituitary; 2012 Dec; 15(4):562-70. PubMed ID: 22183781
[TBL] [Abstract][Full Text] [Related]
53. The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
Karavitaki N; Fernandez A; Fazal-Sanderson V; Wass JA
Clin Endocrinol (Oxf); 2009 Dec; 71(6):840-5. PubMed ID: 19320648
[TBL] [Abstract][Full Text] [Related]
54. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
55. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
Wang YY; Waqar M; Abou-Zeid A; Kearney T; Caputo C; Davis J; Trainer P; Higham C; Roncaroli F; Gnanalingham KK
Neuroendocrinology; 2022; 112(4):345-357. PubMed ID: 34052822
[TBL] [Abstract][Full Text] [Related]
56. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
[TBL] [Abstract][Full Text] [Related]
57. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
[TBL] [Abstract][Full Text] [Related]
58. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
Montefusco L; Filopanti M; Ronchi CL; Olgiati L; La-Porta C; Losa M; Epaminonda P; Coletti F; Beck-Peccoz P; Spada A; Lania AG; Arosio M
Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065
[TBL] [Abstract][Full Text] [Related]
59. Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L.
Rosario PW; Calsolari MR
Arch Endocrinol Metab; 2017; 61(5):426-431. PubMed ID: 28977166
[TBL] [Abstract][Full Text] [Related]
60. Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients.
Bogazzi F; Ultimieri F; Raggi F; Costa A; Gasperi M; Cecconi E; Mosca F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2002 May; 87(5):2403-6. PubMed ID: 11994396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
